Clinical trials
Coronary Disease trials in Spain with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2015 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fundación EPIC | 4 |
| Abbott Medical Devices | 1 |
| Ad scientiam | 1 |
| Andres Iñiguez Romo, MD, PhD | 1 |
| Basque Health Service | 1 |
| Centro per la Lotta Contro l'Infarto - Fondazione Onlus | 1 |
| Ceric Sàrl | 1 |
| Corporacion Parc Tauli | 1 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 1 |
| Imperial College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 22 |
| Coronary Artery Disease | 9 |
| Myocardial Ischemia | 6 |
| Cardiovascular Diseases | 4 |
| Coronary Stenosis | 3 |
| Acute Coronary Syndrome | 2 |
| Heart Diseases | 2 |
| ST Elevation Myocardial Infarction | 2 |
| Arteriosclerosis | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.